Spectral AI, Inc. (MDAI)
1.625
+0.02
(+0.93%)
USD |
NASDAQ |
Aug 27, 16:00
1.66
+0.04
(+2.15%)
After-Hours: 20:00
Spectral AI Enterprise Value : 54.09M for Aug. 26, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 54.09M |
| August 25, 2026 | 54.74M |
| August 24, 2026 | 53.77M |
| August 21, 2026 | 53.77M |
| August 20, 2026 | 52.81M |
| August 19, 2026 | 54.42M |
| August 18, 2026 | 54.09M |
| August 17, 2026 | 55.06M |
| August 14, 2026 | 56.35M |
| August 13, 2026 | 57.96M |
| August 12, 2026 | 52.81M |
| August 11, 2026 | 57.31M |
| August 10, 2026 | 57.31M |
| August 07, 2026 | 58.60M |
| August 06, 2026 | 55.70M |
| August 05, 2026 | 54.74M |
| August 04, 2026 | 55.38M |
| August 03, 2026 | 54.09M |
| July 31, 2026 | 52.16M |
| July 30, 2026 | 53.13M |
| July 29, 2026 | 50.55M |
| July 28, 2026 | 52.48M |
| July 27, 2026 | 55.06M |
| July 24, 2026 | 55.06M |
| July 23, 2026 | 55.06M |
| Date | Value |
|---|---|
| July 22, 2026 | 56.02M |
| July 21, 2026 | 56.35M |
| July 20, 2026 | 55.38M |
| July 17, 2026 | 56.02M |
| July 16, 2026 | 55.38M |
| July 15, 2026 | 56.67M |
| July 14, 2026 | 56.02M |
| July 13, 2026 | 56.35M |
| July 10, 2026 | 57.63M |
| July 09, 2026 | 57.63M |
| July 08, 2026 | 57.96M |
| July 07, 2026 | 58.28M |
| July 06, 2026 | 62.46M |
| July 02, 2026 | 59.89M |
| July 01, 2026 | 59.57M |
| June 30, 2026 | 57.96M |
| June 29, 2026 | 52.07M |
| June 26, 2026 | 52.70M |
| June 25, 2026 | 51.43M |
| June 24, 2026 | 51.11M |
| June 23, 2026 | 52.70M |
| June 22, 2026 | 53.34M |
| June 18, 2026 | 56.20M |
| June 17, 2026 | 55.88M |
| June 16, 2026 | 56.20M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Co-Diagnostics, Inc. | 4.248M |
| Fractyl Health, Inc. | 130.54M |
| NovelStem International Corp. | 2.190M |
| IGC Pharma, Inc. | 32.24M |
| Omnicell, Inc. | 1.403B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.176M |
| Revenue (Quarterly) | 3.524M |
| Total Expenses (Quarterly) | 7.70M |
| EPS Diluted (Quarterly) | -0.1302 |
| Gross Profit Margin (Quarterly) | 31.58% |
| Profit Margin (Quarterly) | -118.5% |
| Earnings Yield | -21.63% |
| Normalized Earnings Yield | -27.34 |